Introduction to nine-valent vaccine
The nine-valent vaccine is a vaccine that prevents cancer caused by human papillomavirus (HPV) infection. It protects against HPV-related cancers and other diseases, including cervical, anal, and head and neck cancers. The only FDA-approved nine-valent vaccine brand currently on the market is Merck’s Gardasil 9. The 9-valent vaccine has been recommended as a routine vaccine for adolescents and young adults in the United States and other countries.
Effectiveness and safety of nine-valent vaccine
Since its launch, the nine-valent vaccine has been proven to be very effective and safe. According to clinical trial data submitted by Merck to the FDA, Gardasil 9 is more than 90% effective in preventing HPV infection and HPV-related cancers. Apart from common side effects such as mild pain, redness, swelling and warmth at the injection site, few serious side effects occur.
Controversy over the nine-valent vaccine
Because the launch of Gardasil 9 coincides with the U.S. government\’s Vaccines for Children program, some have accused the government of possible collusion between the government and pharmaceutical companies. They claim that in order to make high profits, the government and pharmaceutical companies forcefully promote the nine-valent vaccine while ignoring other methods of treating cancer. This criticism was widely circulated on social media and triggered some irrational behaviors and remarks. However, these criticisms have little substantive factual basis, because the nine-valent vaccine has been proven to be a safe and effective preventive medicine.
The market impact of the nine-valent vaccine
Since the launch of the nine-valent vaccine in 2015, Merck\’s share price has increased by approximately 90%, which proves the important role and good business prospects of the nine-valent vaccine business for Merck. Now, almost all medical insurance companies cover the cost of the nine-valent vaccine, making this more efficient and safer preventive medicine available to more people. Overall, the launch of the nine-valent vaccine has greatly improved the chances and level of human resistance to HPV diseases.
Summary
The nine-valent vaccine is an efficient, safe and popular medical method to prevent HPV infection and related cancers. Although the nine-valent vaccine has received some controversy and criticism at home and abroad, due to its significant clinical effect and safety, the nine-valent vaccine has become one of the main weapons in the fight against HPV disease and one of the important results of medical research and progress.
